13 reports

Genentech is developing GNE-## for the treatment of asthma.

  • Hospital
  • Ovarian Cancer
  • United States
  • Product Initiative
  • Novartis AG

The ODAC reviewed findings from one Phase III clinical study and one Phase II study.

  • Cancer
  • Oncology
  • Ovarian Cancer
  • Therapy
  • Novartis AG

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.

AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions.

  • Chemotherapy
  • Ovarian Cancer
  • Pharmaceutical
  • Targeted Therapy
  • Therapy
  • PIPELINE BY ABBVIE INC, H1 2018

It is also developing new approaches to the treatment of asthma.

  • Oncology
  • Ovarian Cancer
  • Therapy
  • United States
  • AstraZeneca PLC

It is also developing new approaches to the treatment of asthma.

  • Cancer
  • Ovarian Cancer
  • United States
  • Product Initiative
  • AstraZeneca PLC

Sandoz Generic Advair Diskus®regulatory submission was accepted by FDA for treatment of asthma and airflow obstruction and reducing exacerbations in patients with COPD.

  • Clinical Trial
  • Oncology
  • Ovarian Cancer
  • United States
  • GlobalData's company

The company commercializes medicines for high low-density lipoprotein (LDL) cholesterol, eye diseases and a rare inflammatory condition and also develops medicines for oncology, rheumatoid arthritis (RA), asthma, atopic dermatitis, pain, and infectious diseases.

  • Hospital
  • Ovarian Cancer
  • Therapy
  • Product Initiative
  • Amgen Inc.

It is also developing new approaches to the treatment of asthma.

  • Hospital
  • Ovarian Cancer
  • Therapy
  • United States
  • AstraZeneca PLC

It is also developing new approaches to the treatment of asthma.

  • Hospital
  • Monoclonal Antibody
  • Ovarian Cancer
  • Therapy
  • Merck & Co., Inc.

Its product portfolio includes pharmaceuticals for the treatment of diseases such as type II diabetes, overactive bladder, osteoporosis, Alzheimer' s disease, peripheral circulatory disorder, bronchial asthma and allergic rhinitis, among others.

  • Hospital
  • Monoclonal Antibody
  • Ovarian Cancer
  • Therapy
  • Merck & Co., Inc.

Patients received pegylated liposomal doxorubicin on day ## and GEN-## on days ##, ##, ## and ##.

  • Monoclonal Antibody
  • Ovarian Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • EPITHELIAL OVARIAN CANCER - PIPELINE BY MYCENAX BIOTECH INC, H2 2016

The company' s pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult Crohn' s Disease, and breast cancer; and indications for treatment of patients undergoing chemotherapy.

  • Hospital
  • Ovarian Cancer
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.